Sarah L. Farmer - Publications

Teclistamab in Multiple Myeloma with One to Three Previous Lines of Therapy.

Journal: The New England journal of medicine

Published: May 29, 2026

Mitigating Teclistamab Toxicity: Prophylactic Tocilizumab and Timing of Immunoglobulin Replacement Therapy in a Nationwide Cohort.

Journal: American journal of hematology

Published: March 09, 2026

REALiTEC: a multi-country observational retrospective study of teclistamab in patients with relapsed/refractory multiple myeloma outside of clinical trials.

Journal: Haematologica

Published: September 30, 2025

Bone mineral density and microarchitecture in patients with essential thrombocythemia and polycythemia vera.

Journal: Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA

Published: May 02, 2016

Erratum to: Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers.

Journal: International journal of hematology

Published: August 13, 2015

Bone morbidity in chronic myeloproliferative neoplasms.

Journal: Expert review of hematology

Published: June 04, 2015

Status and perspectives on chronic myeloproliferative neoplasm treatment

Journal: Ugeskrift for laeger

Published: May 14, 2015

Bone geometry, bone mineral density, and micro-architecture in patients with myelofibrosis: a cross-sectional study using DXA, HR-pQCT, and bone turnover markers.

Journal: International journal of hematology

Published: November 27, 2014

Severe osteoporosis in a patient with polycythaemia vera

Journal: Ugeskrift for laeger

Published: October 09, 2014

Chronic myeloproliferative neoplasms and risk of osteoporotic fractures; a nationwide population-based cohort study.

Journal: British journal of haematology

Published: June 18, 2013